Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Rating Scales
BEHAVIORAL
2 trials
Sponsors
AstraZeneca
, Samus Therapeutics, Inc.
Conditions
Alzheimer Disease
Bipolar Disorder
Psychotic Disorders
Schizophrenia
Phase 2
To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia
Terminated
NCT04311515
Samus Therapeutics, Inc.
Alzheimer Disease
Start: 2020-06-30
End: 2022-11-15
Updated: 2022-11-17
Phase 3
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
Terminated
NCT00486798
AstraZeneca
Bipolar Disorder, Psychotic Disorders, Schizophrenia
Start: 2007-05-31
End: 2007-08-31
Updated: 2010-12-10
Related Papers
Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system
Nature Communications
2021-08-03
32 citations